Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), a progressive paralytic disease characterized by loss of motor neurons. With the use of mice carrying a deletable mutant gene, expression within motor neurons was shown to be a primary determinant of disease onset and of an early phase of disease progression. Diminishing the mutant levels in microglia had little effect on the early disease phase but sharply slowed later disease progression. Onset and progression thus represent distinct disease phases defined by mutant action within different cell types to generate non–cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“accumulation of mutant SOD1 in microglia may further amplify their proinflammatory and neurotoxic activity (149, 150).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [150]
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus
Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121
Microglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Self-citationUNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Self-citationWild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Self-citation
Research works printed but not linked: 2
- T. Kawamata, H. Akiyama, T. Yamada, P. L. McGeer, Am. J. Pathol.140, 691 (1992).
- A. Mazzone, G. Ricevuti, Haematologica80, 161 (1995).
Cited by
Items 301–400 of 1,001
Altered perivascular fibroblast activity precedes ALS disease onset
Månberg, A., Skene, N., Sanders, F., Trusohamn, M., Remnestål, J., Szczepińska, A., Aksoylu, I. S., Lönnerberg, P., Ebarasi, L., Wouters, S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01295-9 · Cited by 120
Liang, X., Wang, Q., Shi, J., Lokteva, L., Breyer, R. M., Montine, T. J., & Andreasson, K. (2008) · Annals of Neurology · doi:10.1002/ana.21437 · Cited by 119
Astrocyte heterogeneity in the brain: from development to disease
Schitine, C., Nogaroli, L., Costa, M. R., & Hedin-Pereira, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00076 · Cited by 119
Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis
Fergani, A., Oudart, H., de Aguilar, J. G., Fricker, B., René, F., Hocquette, J.-F. J.-F., Meininger, V., Dupuis, L., & Loeffler, J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700017-jlr200 · Cited by 144
Effects of mitochondrial dysfunction on the immunological properties of microglia
Ferger, A. I., Campanelli, L., Reimer, V., Muth, K. N., Merdian, I., Ludolph, A. C., & Witting, A. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-45 · Cited by 120
Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
Cappello, V., & Francolini, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102092 · Cited by 119
“The pathogenic role of mutant SOD1 expression in microglia has been equally investigated and, also in this case, it was show that by downregulating SOD1 levels in microglial cells in vivo increased the mean survival of the mutant mice by slowing disease progression after onset [101,102].”
BackgroundYoo, Y.-E., & Ko, C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.003 · Cited by 132
Logan, S., Arzua, T., Canfield, S. G., Seminary, E. R., Sison, S. L., Ebert, A. D., & Bai, X. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180025 · Cited by 151
Genetic targeting of microglia
Wieghofer, P., Knobeloch, K.-P., & Prinz, M. (2015) · Glia · doi:10.1002/glia.22727 · Cited by 117
Liu, Y., Hao, W., Dawson, A., Liu, S., & Fassbender, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m804446200 · Cited by 118
Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model
Wang, R., Yang, B., & Zhang, D. (2011) · Glia · doi:10.1002/glia.21167 · Cited by 115
Gravel, M., Béland, L.-C., Soucy, G., Abdelhamid, E., Rahimian, R., Gravel, C., & Kriz, J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0854-15.2016 · Cited by 117
A neurodegenerative disease mutation that accelerates the clearance of apoptotic cells
Kao, A. W., Eisenhut, R. J., Martens, L. H., Nakamura, A., Huang, A., Bagley, J. A., Zhou, P., de Luis, A., Neukomm, L. J., Cabello, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100650108 · Cited by 117
Kim, S. H., Shi, Y., Hanson, K. A., Williams, L. M., Sakasai, R., Bowler, M. J., & Tibbetts, R. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808064200 · Cited by 117
Neuronal autophagy and intercellular regulation of homeostasis in the brain
Kulkarni, A., Chen, J., & Maday, S. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.02.008 · Cited by 117
Li, W., Brakefield, D., Pan, Y., Hunter, D., Myckatyn, T. M., & Parsadanian, A. S. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.028 · Cited by 126
Bravo-Hernandez, M., Tadokoro, T., Navarro, M. R., Platoshyn, O., Kobayashi, Y., Marsala, S., Miyanohara, A., Juhas, S., Juhasova, J., Skalnikova, H., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0674-1 · Cited by 114
Self-citationEffects of dietary restriction on neuroinflammation in neurodegenerative diseases
Fontana, L., Ghezzi, L., Cross, A. H., & Piccio, L. M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190086 · Cited by 122
CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis
Tateishi, T., Yamasaki, R., Tanaka, M., Matsushita, T., Kikuchi, H., Isobe, N., Ohyagi, Y., & Kira, J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.03.004 · Cited by 127
Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1
Cvetanovic, M., Ingram, M., Orr, H., & Opal, P. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.003 · Cited by 114
Signaling by death receptors in the nervous system
Haase, G., Pettmann, B., Raoul, C., & Henderson, C. E. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.07.013 · Cited by 131
Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma
Toth, R. P., & Atkin, J. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01017 · Cited by 114
“Another study using the Cre/Lox system observed slower disease progression upon G37R SOD1 depletion in microglia (122).”
MethodAmyotrophic lateral sclerosis: Current perspectives from basic research to the clinic
Mancuso, R., & Navarro, X. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.004 · Cited by 134
Macrophage Migration Inhibitory Factor as a Chaperone Inhibiting Accumulation of Misfolded SOD1
Israelson, A., Ditsworth, D., Sun, S., Song, S., Liang, J., Hruška-Plocháň, M., McAlonis‐Downes, M., Abu‐Hamad, S., Zoltsman, G., Shani, T., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.034 · Cited by 119
Self-citationWang, L., Sharma, K., Grisotti, G., & Roos, R. P. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.002 · Cited by 114
Nitric Oxide-Mediated Oxidative Damage and the Progressive Demise of Motor Neurons in ALS
Drechsel, D. A., Estévez, A. G., Barbeito, L., & Beckman, J. S. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9322-y · Cited by 113
Woodling, N. S., Wang, Q., Priyam, P. G., Larkin, P., Shi, J., Johansson, J. U., Zagol-Ikapitte, I., Boutaud, O., & Andreasson, K. I. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0410-14.2014 · Cited by 112
Ilieva, H. S., Yamanaka, K., Malkmus, S., Kakinohana, O., Yaksh, T., Marsala, M., & Cleveland, D. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805422105 · Cited by 113
Self-citationRojas, F., Cortes, N., Abarzua, S., Dyrda, A., & van Zundert, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00024 · Cited by 113
Do Microglial Sex Differences Contribute to Sex Differences in Neurodegenerative Diseases?
Kodama, L., & Gan, L. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.05.001 · Cited by 112
Ludolph, A. C., Bendotti, C., Blaugrund, E., Hengerer, B., Löffler, J., Martin, J., Meininger, V., Meyer, T., Moussaoui, S., Robberecht, W., et al. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701292837 · Cited by 113
Reyes, N. A., Fisher, J. K., Austgen, K., VandenBerg, S., Huang, E. J., & Oakes, S. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42986 · Cited by 113
Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement
Rojas, P., Ramirez, A. I., Fernández‐Albarral, J. A., López‐Cuenca, I., Salobrar‐García, E., Cadena, M., Elvira‐Hurtado, L., Salazar, J. J., de Hoz, R., & Ramirez, J. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.566858 · Cited by 129
Gamo, K., Kiryu-Seo, S., Konishi, H., Aoki, S., Matsushima, K., Wada, K., & Kiyama, H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2920-08.2008 · Cited by 111
Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis
Teng, Y. D., Benn, S. C., Kalkanis, S. N., Shefner, J. M., Onario, R. C., Cheng, B., Lachyankar, M. B., Marconi, M., Li, J., Yu, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004579 · Cited by 115
Neuroprotective Effect of TREM-2 in Aging and Alzheimer’s Disease Model
Raha, A. A., Henderson, J. W., Stott, S. R. W., Vuono, R., Foscarin, S., Friedland, R. P., Zaman, S. H., & Raha-Chowdhury, R. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160663 · Cited by 111
Martin, E., El-Behi, M., Fontaine, B., & Delarasse, C. (2017) · Journal of Visualized Experiments · doi:10.3791/55781 · Cited by 104
Glial Cells in Amyotrophic Lateral Sclerosis
Lasiene, J., & Yamanaka, K. (2011) · Neurology Research International · doi:10.1155/2011/718987 · Cited by 110
Self-citationHefferan, M. P., Gálik, J., Kakinohana, O., Sekerková, G., Santucci, C., Marsala, S., Navarro, R., Hruška-Plocháň, M., Johe, K. K., Feldman, E. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042614 · Cited by 115
Self-citationXia, Q., Hu, Q., Wang, H., Yang, H., Gao, F., Ren, H., Chen, D., Fu, C., Zheng, L., Zhen, X., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.69 · Cited by 108
Patel, P., Kriz, J., Gravel, M., Soucy, G., Bareil, C., Gravel, C., & Julien, J.-P. (2014) · Molecular Therapy · doi:10.1038/mt.2013.239 · Cited by 110
Yeung, A. W. K., Tzvetkov, N. T., Georgieva, M. G., Ognyanov, I. V., Kordos, K., Jóźwik, A., Kühl, T., Perry, G., Petralia, M. C., Mazzon, E., et al. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7952 · Cited by 110
Abati, E., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1738390 · Cited by 116
New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases
Scarian, E., Viola, C., Dragoni, F., Gerlando, R. D., Rizzo, B., Diamanti, L., Gagliardi, S., Bordoni, M., & Pansarasa, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052698 · Cited by 129
Tolosa, L., Mir, M., Asensio, V. J., Olmos, G., & Lladó, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05206.x · Cited by 110
Apolloni, S., Amadio, S., Montilli, C., Volonte, C., & D'Ambrosi, N. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt259 · Cited by 109
“However, during ALS progression, microglia activation, which occurs before evident motoneuron damage and well before clinical disease onset (9), is known to be a double-edged sword, with the ability to promote both neuronal protection (M2 microglia) and injury (M1 microglia) (15).”
BackgroundMesci, P., Zaïdi, S., Lobsiger, C. S., Millecamps, S., Escartin, C., Seilhean, D., Sato, H., Mallat, M., & Boillée, S. (2015) · Brain · doi:10.1093/brain/awu312 · Cited by 109
Self-citationNeuron-microglia signaling: Chemokines as versatile messengers
Biber, K., Vinet, J., & Boddeke, H. W. G. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.012 · Cited by 108
Mead, R. J., Bennett, E. J., Kennerley, A. J., Sharp, P., Sunyach, C., Kasher, P., Berwick, J., Pettmann, B., Battaglia, G., Azzouz, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023244 · Cited by 108
Antisense drugs make sense for neurological diseases
Bennett, C. F., Kordasiewicz, H. B., & Cleveland, D. W. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023738 · Cited by 108
Self-citationYamazaki, T., Nalbandian, A., Uchida, Y., Li, W., Arnold, T. D., Kubota, Y., Yamamoto, S., Ema, M., & Mukouyama, Y. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.069 · Cited by 113
Vinsant, S., Mansfield, C., Jimenez‐Moreno, R., Moore, V. D. G., Yoshikawa, M., Hampton, T. G., Prevette, D., Caress, J., Oppenheim, R. W., & Milligan, C. (2013) · Brain and Behavior · doi:10.1002/brb3.143 · Cited by 105
Gowing, G., Dequen, F., Soucy, G., & Julien, J.-P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0602-06.2006 · Cited by 106
Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats
Huang, C., Tong, J., Bi, F., Zhou, H., & Xia, X.-G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59130 · Cited by 105
Kaiser, M., Maletzki, I., Hülsmann, S., Holtmann, B., Schulz‐Schaeffer, W., Kirchhoff, F., Bähr, M., & Neusch, C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04131.x · Cited by 105
Furukawa, Y., Kaneko, K., Yamanaka, K., & Nukina, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.113597 · Cited by 105
Self-citationThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
Doty, K. R., Guillot-Sestier, M.-V., & Town, T. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.008 · Cited by 104
Targeting of Monomer/Misfolded SOD1 as a Therapeutic Strategy for Amyotrophic Lateral Sclerosis
Liu, H.-N., Tjostheim, S., DaSilva, K., Taylor, D., Zhao, B., Rakhit, R., Brown, M., Chakrabartty, A., McLaurin, J., & Robertson, J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5053-11.2012 · Cited by 118
Massie, A., Boillée, S., Hewett, S., Knackstedt, L., & Lewerenz, J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13348 · Cited by 103
Su, W., Hopkins, S., Nesser, N. K., Sopher, B., Silvestroni, A., Ammanuel, S., Jayadev, S., Möller, T., Weinstein, J., & Garden, G. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301397 · Cited by 103
Roberts, K., Zeineddine, R., Corcoran, L., Li, W., Campbell, I. L., & Yerbury, J. J. (2013) · Glia · doi:10.1002/glia.22444 · Cited by 103
Chaperone-like activity of the AAA+ proteins Rvb1 and Rvb2 in the assembly of various complexes
Nano, N., & Houry, W. A. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0399 · Cited by 120
Ageing as a risk factor for ALS/FTD
Niccoli, T., Partridge, L., & Isaacs, A. M. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx247 · Cited by 102
Miao, J., Chen, L., Pan, X., Li, L.-Q., Zhao, B., & Lan, J. X. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01376-y · Cited by 129
Mechanisms of activation and repression by the alternative splicing factors RBFOX1/2
Sun, S., Zhang, Z., Fregoso, O., & Krainer, A. R. (2012) · RNA · doi:10.1261/rna.030486.111 · Cited by 103
Standley, J. M. (1998) · PubMed · Cited by 134
Gerbino, V., Kaunga, E., Ye, J., Canzio, D., O’Keeffe, S., Rudnick, N. D., Guarnieri, P., Lutz, C. M., & Maniatis, T. (2020) · Neuron · doi:10.1016/j.neuron.2020.03.005 · Cited by 102
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Peggion, C., Calí, T., & Brini, M. (2024) · Antioxidants · doi:10.3390/antiox13020240 · Cited by 124
Boucherie, C., Schäfer, S., Lavand'homme, P., Maloteaux, J., & Hermans, E. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22038 · Cited by 102
Microglia-targeting nanotherapeutics for neurodegenerative diseases
Zhao, N., Francis, N. L., Calvelli, H. R., & Moghe, P. V. (2020) · APL Bioengineering · doi:10.1063/5.0013178 · Cited by 104
Early and Persistent Abnormal Decoding by Glial Cells at the Neuromuscular Junction in an ALS Model
Arbour, D., Tremblay, E., Martineau, É., Julien, J., & Robitaille, R. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1379-14.2015 · Cited by 106
Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging
Tian, F., Yang, W., Mordes, D. A., Wang, J., Salameh, J. S., Mok, J., Chew, J., Sharma, A., Leno‐Durán, E., Suzuki-Uematsu, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms13283 · Cited by 105
Tefera, T. W., & Borges, K. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00611 · Cited by 100
Wang, L., Sharma, K., Deng, H.-X., Siddique, T., Grisotti, G., Liu, E., & Roos, R. P. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.10.004 · Cited by 99
An enhanced integrated stress response ameliorates mutant SOD1-induced ALS
Wang, L., Popko, B., & Roos, R. P. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt658 · Cited by 100
Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration
Wilkins, H. M., Weidling, I. W., Ji, Y., & Swerdlow, R. H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00508 · Cited by 102
Keller, A. F., Gravel, M., & Križ, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.010 · Cited by 112
Rao, M. V., McBrayer, M. K., Campbell, J., Kumar, A., Hashim, A., Sershen, H., Stavrides, P. H., Ohno, M., Hutton, M., & Nixon, R. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1132-14.2014 · Cited by 99
Doss, S. V., Kemp, Z., Hatzipetros, T., Vieira, F. G., & Valdez, G. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23848 · Cited by 105
The microbiota–microglia axis in central nervous system disorders
Mossad, O., & Erny, D. (2020) · Brain Pathology · doi:10.1111/bpa.12908 · Cited by 98
CD44 expression in astrocytes and microglia is associated with ALS progression in a mouse model
Matsumoto, T., Imagama, S., Hirano, K., Ohgomori, T., Natori, T., Kobayashi, K., Muramoto, A., Ishiguro, N., & Kadomatsu, K. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.05.048 · Cited by 80
Allodi, I., Montañana-Rosell, R., Selvan, R., Löw, P., & Kiehn, O. (2021) · Nature Communications · doi:10.1038/s41467-021-23224-7 · Cited by 101
Meininger, V., Drory, V. E., Leigh, P. N., Ludolph, A., Robberecht, W., & Silani, V. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960902803432 · Cited by 97
Dyke, J. M. V., Smit-Oistad, I. M., Macrander, C., Krakora, D., Meyer, M. G., & Suzuki, M. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.01.008 · Cited by 108
Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cernasov, P., Reynolds, B., Pijanowski, O., Chonde, D. B., Izquierdo Garcia, D., Mainero, C., Catana, C., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25251 · Cited by 97
Giorgini, F., Möller, T., Kwan, W., Zwilling, D., Wacker, J. L., Hong, S., Tsai, L.-C. L., Cheah, C. S., Schwarcz, R., Guidetti, P., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708192200 · Cited by 97
Eitan, E., Tichon, A., Gazit, A., Gitler, D., Slavin, S., & Priel, E. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200212 · Cited by 82
Vinceti, M., Bottecchi, I., Fan, A., Finkelstein, Y., & Mandrioli, J. (2012) · Reviews on Environmental Health · doi:10.1515/reveh-2012-0002 · Cited by 97
Cellular functions of optineurin in health and disease
Slowicka, K., Vereecke, L., & van Loo, G. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.07.002 · Cited by 96
Kawamata, H., Ng, S. K., Diaz, N., Burstein, S., Morel, L., Osgood, A., Sider, B., Higashimori, H., Haydon, P. G., Manfredi, G., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2689-13.2014 · Cited by 97
“Pathological analysis of genetically chimeric mice, in which the SOD1 mutant is selectively excised from different CNS cell types, demonstrated that various glial cells significantly promote disease progression (Boillée et al., 2006; Yamanaka et al., 2008; Kang et al., 2013).”
BackgroundCombining growth factor and stem cell therapy for amyotrophic lateral sclerosis
Suzuki, M., & Svendsen, C. N. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.01.006 · Cited by 101
Johansson, J. U., Pradhan, S., Lokteva, L. A., Woodling, N. S., Ko, N., Brown, H. D., Wang, Q., Loh, C., Cekanaviciute, E., Buckwalter, M., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2203-13.2013 · Cited by 96
Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS
Allodi, I., Comley, L., Nichterwitz, S., Nizzardo, M., Simone, C., Benitez, J. A., Cao, M., Corti, S., & Hedlund, E. (2016) · Scientific Reports · doi:10.1038/srep25960 · Cited by 96
Gingras, M., Beaulieu, M., Gagnon, V., Durham, H. D., & Berthod, F. (2007) · Glia · doi:10.1002/glia.20617 · Cited by 113
Markovinović, A., Cimbro, R., Ljutić, T., Križ, J., Rogelj, B., & Munitić, I. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.005 · Cited by 100
Revisiting oxidative damage in ALS: microglia, Nox, and mutant SOD1
Boillée, S., & Cleveland, D. W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34613 · Cited by 95
Self-citationHarlan, B. A., Pehar, M., Sharma, D. R., Beeson, G., Beeson, C. C., & Vargas, M. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698779 · Cited by 94
Figueroa-Romero, C., Guo, K., Murdock, B. J., Paez-Colasante, X., Bassis, C. M., Mikhail, K. A., Raue, K. D., Evans, M. C., Taubman, G. F., McDermott, A. J., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.041947 · Cited by 94
Wang, X., Zhang, Q., Bao, R., Zhang, N., Wang, Y., Polo‐Parada, L., Tarim, A. O., Alemifar, A., Han, X., Wilkins, H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.022 · Cited by 93
Cross-talk between microglia and neurons regulates HIV latency
Alvarez-Carbonell, D., Ye, F., Ramanath, N., García‐Mesa, Y., Knapp, P. E., Hauser, K. F., & Karn, J. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008249 · Cited by 101
Metadata
- Authors
- Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W.
- Affiliations
- Ludwig Institute for Cancer Research and Departments of Medicine and Neuroscience, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- ORCID
- Venue
- Science
- Published
- 2006-06-02
- Volume
- 312
- Issue
- 5778
- Pages
- 1389-1392
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2033158384
- Cited by
- 1,623
- References
- 28
- Citations by year
- 2026: 42 · 2025: 40 · 2024: 52 · 2023: 59 · 2022: 69 · 2021: 60 · 2020: 95 · 2019: 82 · 2018: 74 · 2017: 84 · 2016: 82 · 2015: 81 · 2014: 109 · 2013: 107 · 2012: 115
- FWCI
- 66.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS 27036, R37NS027036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, motor neurons, microglia, disease onset, disease progression, cell replacement therapy, mouse model
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Motor Neurons, Mutation, Superoxide Dismutase, Microglia, Disease Progression, Integrases, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.